Aspirin’s anti-inflamatory effect plays a role in minimizing cancerous tumors.

The news is promising development in the treatment of cancer.

“This discovery unlocks a range of potentially powerful new therapies to target this pathway in lymphatic vessels, effectively tightening a tumor’s supply lines and restricting the transport of cancer cells to the rest of the body.”

An aspirin a day used to be the recommendation for stroke and heart attack patients for preventative measures.

However the risk of heavy internal bleeding is worse than the potential benefits, especially to healthy people.

The message seems to be that aspirin therapy causes more harm than it’s worth.

Currently, U.S. guidelines all recommend aspirin for primary prevention as long as the benefits outweigh the harms, an equation that depends on baseline risk. This advice is backed by an editorial accompanying the new report.